Gabor Pal
Budapest, BU, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Efficient production of fully active, SARS-CoV-2-priming, wildtype TMPRSS2 ectodomain via co-expression of HAI-2 allows for both auto- and cross-activation mechanisms.
Journal: The Biochemical journal
Published: September 25, 2025
Elevated Plasma MBL Levels Are Associated With Risk of Future Venous Thromboembolism: The HUNT Study.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: May 15, 2025
Targeting the complement lectin pathway with a highly specific MASP-2 inhibitor protects against renal ischemia-reperfusion injury.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 14, 2025
Engineering mouse chymotrypsin B1 for improved trypsinogen degradation.
Journal: Scientific reports
Published: January 25, 2025
To be, or not to be cleaved: Directed evolution of a canonical serine protease inhibitor against active and inactive protease pair identifies binding loop residue critical for prevention of proteolytic cleavage.
Journal: Protein science : a publication of the Protein Society
Published: December 22, 2024
Praziquantel and factor H recruitment differentially affect the susceptibility of Schistosoma mansoni to complement-mediated damage.
Journal: Frontiers in immunology
Published: August 01, 2024
The High-Affinity Chymotrypsin Inhibitor Eglin C Poorly Inhibits Human Chymotrypsin-Like Protease: Gln192 and Lys218 Are Key Determinants.
Journal: Proteins
Published: May 28, 2024
SARS-CoV-2 Nucleocapsid Protein Is Not Responsible for Over-Activation of Complement Lectin Pathway.
SARS-CoV-2 Nucleocapsid Protein Is Not Responsible for Over-Activation of Complement Lectin Pathway.
Journal: International journal of molecular sciences
Published: May 20, 2024
Substrate specificity of human chymotrypsin-like protease (CTRL) characterized by phage display-selected small-protein inhibitors.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: August 04, 2023
Correction: Synergy of protease-binding sites within the ecotin homodimer is crucial for inhibition of MASP enzymes and for blocking lectin pathway activation.
Journal: The Journal of biological chemistry
Published: December 23, 2022
Arg236 in human chymotrypsin B2 (CTRB2) is a key determinant of high enzyme activity, trypsinogen degradation capacity, and protection against pancreatitis.
Journal: Biochimica et biophysica acta. Proteins and proteomics
Published: June 10, 2022
Last Updated: 09/26/2026